Original Research
Accepted on 22 Nov 2024
Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA-and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients
in Cancer Immunity and Immunotherapy